Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

Hoster, Eva; Delfau-Larue, Marie-Helene; Macintyre, Elizabeth; Jiang, Linmiao; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles; Thieblemont, Catherine; Tilly, Herve; Wirths, Stefan; Feugier, Pierre; Huebel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C.; Dreyling, Martin; Pott, Christiane

dc.contributor.author	Wirths, Stefan
dc.date.accessioned	2025-04-01T06:06:57Z
dc.date.available	2025-04-01T06:06:57Z
dc.date.issued	2024
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/163511
dc.language.iso	en	de_DE
dc.publisher	Philadelphia : Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.23.00899	de_DE
dc.subject.ddc	610	de_DE
dc.title	Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_02777
utue.publikation.seiten	538-549	de_DE
utue.personen.roh	Hoster, Eva
utue.personen.roh	Delfau-Larue, Marie-Helene
utue.personen.roh	Macintyre, Elizabeth
utue.personen.roh	Jiang, Linmiao
utue.personen.roh	Stilgenbauer, Stephan
utue.personen.roh	Vehling-Kaiser, Ursula
utue.personen.roh	Salles, Gilles
utue.personen.roh	Thieblemont, Catherine
utue.personen.roh	Tilly, Herve
utue.personen.roh	Wirths, Stefan
utue.personen.roh	Feugier, Pierre
utue.personen.roh	Huebel, Kai
utue.personen.roh	Schmidt, Christian
utue.personen.roh	Ribrag, Vincent
utue.personen.roh	Kluin-Nelemans, Johanna C.
utue.personen.roh	Dreyling, Martin
utue.personen.roh	Pott, Christiane
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	42	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE